Matthews International Corporation

Pittsburgh, PA ManufacturingNAICS 331400

Self-funded health planPlan year 2025Renews January
4,336Participants-4% vs. prior year
$10.3MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#13 of 105Manufacturing in PABy participants

Overview

Matthews International Corporation sponsors a self-funded health plan that covered 4,336 participants in plan year 2025, down 4% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
4,336 · prior year 4,517
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Matthews International Corporation Employees Group Insurance Plan, plan 501 (4,336 participants)
Broker compensation
$299K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Lincoln National Life Insurance CompanyLife, Short-term disability, Long-term disability4,336$4.2M$55K
United Concordia Insurance CompanyDental5,534$1.6M$84K
The Lincoln National Life Insurance CompanyAccident, Critical Illness, Hospital1,141$660K$150K
Eyemed Vision Care on Behalf of Fidelity Security Life Insurance Co.Vision4,548$442K—
Highmark Inc.Medicare Advantage143$398K—
Transamerica Life Insurance CompanyLife221$122K$10K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$10.3M/ year

Estimated prescription spend: 4,336 participants × $2,371 national average per member. Usually higher once dependents are counted.

$267K–$659K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$78K–$195K
Lower-cost therapeutic alternatives$114K–$239K
Generic pricing vs. actual cost$49K–$148K
PBM contract terms$26K–$77K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Matthews International Corporation
Sponsor EIN
25-0644320
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 25-0644320 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Matthews International Corporation 401(k) Plan
Type
401(k) plan
Participants
5,387

About this data

Source: Matthews International Corporation's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Matthews International Corporation.

Request a correction · Methodology